Unfortunately, that's been the case for longer term Castle Biosciences, Inc. (NASDAQ:CSTL) shareholders, since the share price is down 34% in the last three years, falling well short of the market ...

Unfortunately, that's been the case for longer term Castle Biosciences, Inc. (NASDAQ:CSTL) shareholders, since the share price is down 34% in the last three years, falling well short of the market ...

Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The firm offers DecisionDx-Melanoma ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Castle Biosciences Inc (Symbol: CSTL), where a total of 2,062 contracts have traded so ...

Shares of Castle Biosciences, Inc. (CSTL) have gained 1.5% over the past four weeks to close the last trading session at $27.06, but there could still be a solid upside left in the stock if short ...

Castle Biosciences, Inc. is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients. The firm offers DecisionDx-Melanoma ...

Leerink Partners analyst Puneet Souda has maintained their bullish stance on CSTL stock, giving a Buy rating yesterday. Puneet Souda has given his Buy rating due to a combination of factors ...

Buy CSTL near 25.93 target 30.71 stop loss @ 25.86 Details The technical summary data tells us to buy CSTL near 25.93 with an upside target of 30.71. This data also tells us to set a stop loss @ 25.86 ...

NASDAQ:CSTL opened at $26.44 on Thursday. The stock’s 50-day simple moving average is $28.58 and its 200 day simple moving average is $28.17. The firm has a market capitalization of $740.58 ...